Reitan Colleen F Insider Trades

Insider Trading History

Track insider trading activity for Reitan Colleen F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $959k 152,030 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$280k 59,701 shares
$4.69
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $404k 1,446 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 2,112 shares
$298.48
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $5.24M 18,775 shares
Last Trade
Sep 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.68M 18,000 shares
$482.13
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $4.78M 17,130 shares
Last Trade
Sep 09, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.42M 18,000 shares
$467.60
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Sep 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.68M 18,000 shares
$482.13
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $583k 92,329 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 49,796 shares
$4.92
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $435k 1,558 shares
Last Trade
May 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 1,558 shares
$258.35
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Apr 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.38k 36 shares
$232.86
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $10k 36 shares
Last Trade
Oct 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.21k 4 shares
$302.67
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $268k 42,533 shares
Last Trade
Sep 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.29M 46,012 shares
$27.95
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $8.93k 32 shares
Last Trade
Aug 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.15k 32 shares
$286.00
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $559k 88,545 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 15,695 shares
$22.30
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.46M 5,228 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$791k 5,228 shares
$151.22
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $460k 72,850 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 15,151 shares
$23.10
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $964k 3,454 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 3,454 shares
$189.87
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $364k 57,699 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 17,275 shares
$20.26
$6.31
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.44M 5,153 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 10,306 shares
$128.31
$279.14
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.13M 4,032 shares
Last Trade
Jul 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$693k 4,032 shares
$171.95
$279.14
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $255k 40,424 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 12,848 shares
$27.24
$6.31
Myriad Genetics
Myriad Genetics MYGN
Director
Holding Value $174k 27,576 shares
Last Trade
Dec 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 15,889 shares
$18.88
$6.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up